Literature DB >> 17108265

Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis.

Lucas Smith, Barbara Rose, Pholawat Tingpej, Hua Zhu1, Tim Conibear2, Jim Manos, Peter Bye3, Mark Elkins3, Mark Willcox2,1, Scott Bell4, Claire Wainwright5, Colin Harbour.   

Abstract

Protease IV is important in the pathogenesis of Pseudomonas aeruginosa-induced microbial keratitis, but little is known of its role in cystic fibrosis (CF) lung infection. In this study protease IV production was examined in 43 P. aeruginosa isolates (24 non-clonal and 19 clonal) from the lungs of chronically infected adult patients attending the Royal Prince Alfred Hospital CF Clinic, Sydney, Australia. Overall, 32/43 (74 %) isolates were positive for protease IV protein by Western blotting and 22/43 (51 %) had evidence of active protease IV on gelatin zymography. Clonal strains were 1.6 times more likely than non-clonal strains to produce protease IV [18/19 (95 %) versus 14/24 (58 %), RR=1.6, CI 1.1-2.3, P=0.007] and 3 times more likely to secrete the protein [16/19 (84 %) versus 6/24 (25 %), RR=3.4, CI 1.6-6.9, P<0.001]. Nine of the ten strains negative by both Western blotting and zymography were non-clonal, and all but one of these was positive for the protease IV gene. There was a marked strain-to-strain variation in the amount of protease IV produced. Secretion of protease IV by clonal strains may enhance their infectivity and ability to adapt to the changing CF lung environment. Overall the findings suggest that protease IV plays an important role in the pathogenesis of P. aeruginosa infection in the CF lung.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108265     DOI: 10.1099/jmm.0.46845-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  14 in total

1.  Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense.

Authors:  Antoine Guillon; Deborah Brea; Eric Morello; Aihua Tang; Youenn Jouan; Reuben Ramphal; Brice Korkmaz; Magdiel Perez-Cruz; Francois Trottein; Richard J O'Callaghan; Philippe Gosset; Mustapha Si-Tahar
Journal:  Virulence       Date:  2016-10-28       Impact factor: 5.882

2.  Serine proteases degrade airway mucins in cystic fibrosis.

Authors:  Markus O Henke; Gerrit John; Christina Rheineck; Shashi Chillappagari; Lutz Naehrlich; Bruce K Rubin
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

3.  Role of Pseudomonas aeruginosa quorum sensing (QS) molecules on the viability and cytokine profile of human mesenchymal stem cells.

Authors:  Alina-Maria Holban; Coralia Bleotu; Mariana Carmen Chifiriuc; Eugenia Bezirtzoglou; Veronica Lazar
Journal:  Virulence       Date:  2014-01-07       Impact factor: 5.882

4.  Proteolytic cleavage of a C-terminal prosequence, leading to autoprocessing at the N Terminus, activates leucine aminopeptidase from Pseudomonas aeruginosa.

Authors:  Robert Sarnovsky; Jennifer Rea; Matt Makowski; Ralf Hertle; Colleen Kelly; Antonella Antignani; Diana V Pastrana; David J Fitzgerald
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

5.  Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media.

Authors:  Audrey Bellemare; Nathalie Vernoux; Dany Morisset; Yves Bourbonnais
Journal:  Antimicrob Agents Chemother       Date:  2007-11-19       Impact factor: 5.191

6.  Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis.

Authors:  Pholawat Tingpej; Lucas Smith; Barbara Rose; Hua Zhu; Tim Conibear; Khaled Al Nassafi; Jim Manos; Mark Elkins; Peter Bye; Mark Willcox; Scott Bell; Claire Wainwright; Colin Harbour
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

7.  Screening of molecular virulence markers in Staphylococcus aureus and Pseudomonas aeruginosa strains isolated from clinical infections.

Authors:  Ani-Ioana Cotar; Mariana-Carmen Chifiriuc; Sorin Dinu; Marcela Bucur; Carmen Iordache; Otilia Banu; Olguta Dracea; Cristina Larion; Veronica Lazar
Journal:  Int J Mol Sci       Date:  2010-12-21       Impact factor: 5.923

8.  Pyocyanina contributory factor in haem acquisition and virulence enhancement of Porphyromonas gingivalis in the lung [corrected].

Authors:  Malgorzata Benedyk; Dominic P Byrne; Izabela Glowczyk; Jan Potempa; Mariusz Olczak; Teresa Olczak; John W Smalley
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

9.  Post-secretional activation of Protease IV by quorum sensing in Pseudomonas aeruginosa.

Authors:  Jungmin Oh; Xi-Hui Li; Soo-Kyong Kim; Joon-Hee Lee
Journal:  Sci Rep       Date:  2017-06-30       Impact factor: 4.379

Review 10.  Evolutionary conservation of the antimicrobial function of mucus: a first defence against infection.

Authors:  Cassie R Bakshani; Ana L Morales-Garcia; Mike Althaus; Matthew D Wilcox; Jeffrey P Pearson; John C Bythell; J Grant Burgess
Journal:  NPJ Biofilms Microbiomes       Date:  2018-07-04       Impact factor: 7.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.